<DOC>
	<DOCNO>NCT00691678</DOCNO>
	<brief_summary>Investigators hop learn glucosamine chondroitin help relieve joint pain/stiffness associate aromatase inhibitor</brief_summary>
	<brief_title>Glucosamine Chondroitin Aromatase Inhibitor Induced Joint Symptoms Women With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>Age &gt; 21 year Postmenopausal status define cessation menses &gt; 1 year FSH &gt; 20 mIU/mL History stage I , II IIIA hormone receptorpositive breast cancer , without metastatic disease Currently take thirdgeneration aromatase inhibitor least 3 month Clinical symptom knee and/or hand joint pain and/or stiffness least 3 month prior study entry Ongoing musculoskeletal pain/stiffness hand and/or knee joint ( 50 high 100 point global assessment VAS ) start increase since initiate aromatase inhibitor therapy , present least 3 month . patient must agree refrain use glucosamine chondroitin source outside study If take bisphosphonates , stable dose least 3 month tolerate dose . Patients must agree refrain initiate bisphosphonate use course study . ECOG performance status 02 . Hemoglobin A1c &lt; 8 . Signed informed consent se glucosamine chondroitin within past six month Concurrent medical/arthritic disease could confound interfere evaluation pain efficacy include : Inflammatory arthritis ( e.g. , rheumatoid arthritis , systemic lupus , spondyloarthropathy , psoriatic arthritis , polymyalgia rheumatica ) gout episode acute monarticular arthritis clinically consistent pseudogout Paget 's disease affect study joint history septic arthritis avascular necrosis intraarticular fracture study joint Wilson 's disease hemochromatosis alkaptonuria primary osteochondromatosis History significant collateral ligament , anterior cruciate ligament meniscal injury index joint require surgery nonweight bearing ( require use crutch cane ) 3 week ( minor ligamentous injury prior 6 month exclusion ) . History bone fracture surgery afflict knee and/or hand within 6 month prior study entry . AST , ALT &gt; 2x normal . Serum Creatinine &gt; 1.8 mg/dl . Uncontrolled hypertension ( Systolic Blood Pressure &gt; 150 mm Hg Diastolic Blood Pressure &gt; 95 mm Hg ) . Uncontrolled diabetes mellitus , define Hemoglobin A1c level &gt; 8 % .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>aromatase inhibitor</keyword>
	<keyword>supportive care</keyword>
</DOC>